Watch out for Neuralstem Inc. (NYSEMKT:CUR), Westinghouse Solar Inc (OTCMKTS:WEST)
Miami, FL 05/17/2013 (GDPInsider) – Neuralstem Inc. (NYSEMKT:CUR) on Thursday traded up by 11.54% to close at $1.45, with total traded volumes of 1.79 million in comparison to its average volume of 0.420 million shares. The market capitalization of the company is $99.76 million at the current price levels. The stock traded below its 52-week high of $1.96 and is above its 52-week low of $0.42. Neuralstem Inc., a development-stage company focused on the development of treatments for central nervous system disease, reported a net loss of $3,590,000, or $0.05 earnings per share, for the first quarter of 2013, compared with a net loss of $2,453,000, or $0.05 EPS, for the same period in 2012. As on March 31, 2013, Neuralstem had total cash and cash equivalents of approximately $12,659,000. Last month, the company received FDA approval to start the trial of NSI-566 Phase II, for ALS, following the excellent safety and tolerability demonstrated in Phase I.
Is CUR a solid investment at these levels? Get valuable updates and exclusive insights here.
Westinghouse Solar Inc (OTCMKTS:WEST) on Thursday traded up by 9.72% to close at $0.0395, with total traded volumes of 0.209 million in comparison to its average volume of 0.633 million shares. The market capitalization of the company is $1.06 million at the current price levels. The stock traded below its 52-week high of $0.47 and is above its 52-week low of $0.03. Westinghouse, a developer of solar power systems and solar panels with built-in micro inverters, generated $81,000 of revenue, a 96.6% decrease for the first quarter ended March 31, 2013, compared to $2.4 million of revenue for same quarter of 2012. Net loss from continuing operations for quarter was $1.0 million, or $0.04 per share, compared to a net loss from continuing operations of $2.9 million, or $0.17 per share, for the comparable quarter in 2012. As of March 31, 2013, Westinghouse Solar Inc. had approximately $21,000 in cash on hand.
How Should Investors Trade WEST Now? Get the latest trends and data here.
WallStreetAnalyzed.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetAnalyzed.com website, for complete risks and disclosures.